The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
Abstract
Objective: External fistulas represent a disabling manifestation of Crohn's disease with a difficult curability and a high relapse rate despite a large therapeutic armamentarium. Stem cell therapy is a novel and promising approach for treatment of chronic inflammatory conditions. We therefore investigated the feasibility, safety and efficacy of serial intrafistular injections of autologous bone marrow-derived mesenchymal stromal cells (MSCs) in the treatment of fistulising Crohn's disease. Patients and methods: We enrolled 12 consecutive outpatients (eight males, median age 32 years) refractory to or unsuitable for current available therapies. MSCs were isolated from bone marrow and expanded ex vivo to be used for both therapeutic and experimental purposes. Ten patients (two refused) received intrafistular MSC injections (median 4) scheduled every 4 weeks, and were monitored by surgical, MRI and endoscopic evaluation for 12 months afterwards. The feasibility of obtaining at least 50×10 6 MSCs from each patient, the appearance of adverse events, and the efficacy in terms of fistula healing and reduction of both Crohn's disease and perianal disease activity indexes were evaluated. In addition, the percentage of both mucosal and circulating regulatory T cells expressing FoxP3, and the ability of MSCs to influence mucosal T cell apoptosis were investigated. Results: MSC expansion was successful in all cases; sustained complete closure (seven cases) or incomplete closure (three cases) of fistula tracks with a parallel reduction of Crohn's disease and perianal disease activity indexes (p<0.01 for both), and rectal mucosal healing were induced by treatment without any adverse effects. The percentage of mucosal and circulating regulatory T cells significantly increased during the treatment and remained stable until the end of follow up (p<0.0001 and p<0.01, respectively). Furthermore, MSCs have been proven to affect mucosal T cell apoptotic rate. Conclusions: Locally injected MSCs represent a feasible, safe and beneficial therapy in refractory fistulising Crohn's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Spontaneous Human Adult Stem Cell Transformation
Rubio, D., Garcia-Castro, J., Martín, M. C., de la Fuente, R., Cigudosa, J. C., Lloyd, A. C., & Bernad, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4194 · Cited by 1,036
RetractedA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
Self-citationImmunomodulatory properties of mesenchymal stromal cells
Nauta, A. J., & Fibbe, W. E. (2007) · Blood · doi:10.1182/blood-2007-02-069716 · Cited by 1,788
Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells
Glennie, S., Soeiro, I., Dyson, P. J., Lam, E. W.-F., & Dazzi, F. (2005) · Blood · doi:10.1182/blood-2004-09-3696 · Cited by 1,150
Gasche, C., Scholmerich, J., Brynskov, J., DʼHaens, G., Hanauer, S. B., Irvine, J. E., Jewell, D. P., Rachmilewitz, D., Sachar, D. B., Sandborn, W. J., et al. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200002000-00002 · Cited by 1,134
The genetics and immunopathogenesis of inflammatory bowel disease
Cho, J. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2340 · Cited by 940
García-Olmo, D., García-Arranz, M., Herreros, D., Pascual, I., Peiro, C., & Rodríguez-Montes, J. A. (2005) · Diseases of the Colon & Rectum · doi:10.1007/s10350-005-0052-6 · Cited by 799
Garcia-Olmo, D., Herreros, D., Pascual, I., Pascual, J. A., Del-Valle, E., Zorrilla, J., De-La-Quintana, P., Garcia-Arranz, M., & Pascual, M. (2009) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181973487 · Cited by 773
AGA technical review on perianal Crohn’s disease
Sandborn, W. J., Fazio, V. W., Feagan, B. G., & Hanauer, S. B. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.08.025 · Cited by 704
Bernardo, M. E., Zaffaroni, N., Novara, F., Cometa, A. M., Avanzini, M. A., Moretta, A., Montagna, D., Maccario, R., Villa, R., Daidone, M. G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4690 · Cited by 694
Self-citationRen, G., Zhao, X., Zhang, L., Zhang, J., L'Huillier, A., Ling, W., Roberts, A. I., Le, A. D., Shi, S., Shao, C., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902023 · Cited by 656
Røsland, G. V., Svendsen, A., Torsvik, A., Sobala, E., McCormack, E., Immervoll, H., Mysliwietz, J., Tonn, J.-C., Goldbrunner, R., Lønning, P. E., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4630 · Cited by 644
González, M. A., Gonzalez–Rey, E., Rico, L., Büscher, D., & Delgado, M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.11.041 · Cited by 631
Lichtenstein, G. R., Yan, S., Bala, M., Blank, M., & Sands, B. E. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.048 · Cited by 597
Maccario, R., Podestà, M., Moretta, A., Cometa, A. M., Comoli, P., Montagna, D., Daudt, L. E., Ibatici, A., Piaggio, G., Pozzi, S., et al. (2005) · PubMed · Cited by 580
Self-citationBai, L., Lennon, D. P., Eaton, V., Maier, K., Caplan, A. I., Miller, S. D., & Miller, R. H. (2009) · Glia · doi:10.1002/glia.20841 · Cited by 546
Ball, L. M., Bernardo, M. E., Roelofs, H., Lankester, A., Cometa, A., Egeler, R. M., Locatelli, F., & Fibbe, W. E. (2007) · Blood · doi:10.1182/blood-2007-04-087056 · Cited by 533
Self-citationGonzález, M. A., Gonzalez‐Rey, E., Rico, L., Büscher, D., & Delgado, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24405 · Cited by 489
Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease
Van Assche, G. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05909-9 · Cited by 457
Tarte, K., Gaillard, J., Lataillade, J.-J., Fouillard, L., Becker, M., Mossafa, H., Tchirkov, A., Rouard, H., Henry, C., Splingard, M., et al. (2010) · Blood · doi:10.1182/blood-2009-05-219907 · Cited by 430
Ina, K., Itoh, J., Fukushima, K., Kusugami, K., Yamaguchi, T., Kyokane, K., Imada, A., Binion, D. G., Musso, A., West, G. A., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.1081 · Cited by 345
Mesenchymal Stromal Cells: A Novel Treatment Modality for Tissue Repair
Bernardo, M. E., Locatelli, F., & Fibbe, W. E. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04607.x · Cited by 295
Self-citationTorsvik, A., Røsland, G. V., Svendsen, A., Molven, A., Immervoll, H., McCormack, E., Lønning, P. E., Primon, M., Sobala, E., Tonn, J.-C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1305 · Cited by 284
Bernardo, M. E., Avanzini, M. A., Perotti, C., Cometa, A. M., Moretta, A., Lenta, E., Del Fante, C., Novara, F., de Silvestri, A., Amendola, G., et al. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20911 · Cited by 277
Self-citationHuman Mesenchymal Stem Cells Promote Survival of T Cells in a Quiescent State
Benvenuto, F., Ferrari, S., Gerdoni, E., Gualandi, F., Frassoni, F., Pistoia, V., Mancardi, G., & Uccelli, A. (2007) · STEM CELLS · doi:10.1634/stemcells.2007-0068 · Cited by 258
Mesenchymal stem cell‐based therapy: a new paradigm in regenerative medicine
Satija, N. K., Singh, V. K., Verma, Y. K., Gupta, P., Sharma, S., Afrin, F., Sharma, M., Sharma, P., Tripathi, R. P., & Gurudutta, G. U. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00857.x · Cited by 252
Batten, P., Sarathchandra, P., Antoniw, J. W., Tay, S. S., Lowdell, M. W., Taylor, P. M., & Yacoub, M. H. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.2263 · Cited by 217
In Vitro Secreting Profile of Human Mesenchymal Stem Cells
Schinköthe, T., Bloch, W., & Schmidt, A. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0175 · Cited by 207
Boumaza, I., Srinivasan, S., Witt, W. T., Feghali-Bostwick, C., Dai, Y., Garcia-Ocana, A., & Feili-Hariri, M. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.10.004 · Cited by 164
Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells
García, S., Martín, M. C., de la Fuente, R., Cigudosa, J. C., Garcı́a-Castro, J., & Bernad, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.016 · Cited by 158
Tanaka, F., Tominaga, K., Ochi, M., Tanigawa, T., Watanabe, T., Fujiwara, Y., Ohta, K., Oshitani, N., Higuchi, K., & Arakawa, T. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.09.016 · Cited by 129
Hayashi, Y., Tsuji, S., Tsujii, M., Nishida, T., Ishii, S., Iijima, H., Nakamura, T., Eguchi, H., Miyoshi, E., Hayashi, N., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137083 · Cited by 129
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications
Mudter, J., & Neurath, M. F. (2006) · Gut · doi:10.1136/gut.2005.090464 · Cited by 127
Cell therapy for autoimmune diseases
Dazzi, F., van Laar, J. M., Cope, A. P., & Tyndall, A. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2128 · Cited by 93
Bernardo, M. E., Avanzini, M. A., Ciccocioppo, R., Perotti, C. G., Cometa, A. M., Moretta, A., Marconi, M., Valli, M., Novara, F., Bonetti, F., et al. (2009) · Cytotherapy · doi:10.3109/14653240903121260 · Cited by 70
Self-citationAhrendt, M., Hammerschmidt, S. I., Pabst, O., Pabst, R., & Bode, U. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1898 · Cited by 60
Mesenchymal stem cells respond to TNF but do not produce TNF
van den Berk, L. C. J., Jansen, B., Siebers-Vermeulen, K. G. C., Roelofs, H., Figdor, C. G., Adema, G. J., & Torensma, R. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0709467 · Cited by 52
NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis.
Zorzetto, M., Ferrarotti, I., Campo, I., et al. (2005) · PubMed · Cited by 15
Cited by
Clinical Trials with Mesenchymal Stem Cells: An Update
Squillaro, T., Peluso, G., & Galderisi, U. (2016) · Cell Transplantation · doi:10.3727/096368915x689622 · Cited by 1,395
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Bernardo, M. E., & Fibbe, W. E. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.09.006 · Cited by 1,383
Self-citationMesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine
Murphy, M. B., Moncivais, K., & Caplan, A. I. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.94 · Cited by 1,231
Mesenchymal stem cells and immunomodulation: current status and future prospects
Gao, F., Chiu, S. M., Motan, D. A. L., Zhang, Z., Chen, L., Ji, H.-L., Tse, H.-F., Fu, Q.-L., & Lian, Q. (2016) · Cell Death & Disease · doi:10.1038/cddis.2015.327 · Cited by 1,121
Multipotent mesenchymal stromal cells and the innate immune system
Le Blanc, K., & Mougiakakos, D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3209 · Cited by 1,018
Metadata
- Authors
- Ciccocioppo, R., Bernardo, M. E., Sgarella, A., Maccario, R., Avanzini, M. A., Ubezio, C., Minelli, A., Alvisi, C., Vanoli, A., Calliada, F., Dionigi, P., Perotti, C., Locatelli, F., & Corazza, G. R.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2011-01-21
- Volume
- 60
- Issue
- 6
- Pages
- 788-798
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2113933847
- Cited by
- 558
- References
- 40
- FWCI
- 27.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.